about
Pathogenesis of FUS-associated ALS and FTD: insights from rodent modelsProtein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia ContinuumCharacteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS.Mechanisms of disease in frontotemporal lobar degeneration: gain of function versus loss of function effectsNuclear carrier and RNA-binding proteins in frontotemporal lobar degeneration associated with fused in sarcoma (FUS) pathological changes.Heterogeneous ribonuclear protein A3 (hnRNP A3) is present in dipeptide repeat protein containing inclusions in Frontotemporal Lobar Degeneration and Motor Neurone disease associated with expansions in C9orf72 geneArginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS.Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains.Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies.Nuclear trafficking in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.Topography of FUS pathology distinguishes late-onset BIBD from aFTLD-U.ALS-FUS pathology revisited: singleton FUS mutations and an unusual case with both a FUS and TARDBP mutationTransportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations.Transportin 1 accumulates in FUS inclusions in adult-onset ALS without FUS mutation.Transportin 1 colocalization with Fused in Sarcoma (FUS) inclusions is not characteristic for amyotrophic lateral sclerosis-FUS confirming disrupted nuclear import of mutant FUS and distinguishing it from frontotemporal lobar degeneration with FUS iFused in Sarcoma Neuropathology in Neurodegenerative Disease.From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis
P2860
Q28067147-AF86BBB5-330F-4313-8BDE-46D5515C1731Q33653996-C46BA666-DC34-4299-B071-2A3DE1B31D99Q34658928-C8EC6CE1-4F7A-408C-AFD2-0B02CA8E464CQ35928701-06C907E2-AD92-484D-927C-FA3FA75FC837Q36241872-E19C6630-6458-4A44-AA38-12BBF4CB54E5Q36342066-A4A3666F-61EF-46A4-9784-CA1BFB5B6336Q36353873-233C30A4-58F1-4CB7-8E3D-F828B1D26453Q36408540-7775540D-19AC-42DF-81D0-FBF46100FE64Q38382217-7DBAB2EA-6A5F-406A-8F24-ACB02A4470EFQ38819135-3C424BB9-1F4E-47B9-BEC4-05835355B266Q38866202-0B153517-924E-4B72-ABC8-C0BCE52B0C1EQ38920545-3CACC5C0-0FA0-4701-8D20-B012ED7D2209Q41903653-BB641198-6A5C-4BC5-BC76-824C6E8D83C8Q42003982-824A0A53-B7AB-4FB7-9324-9D72C338B4D5Q46624207-1040ADD1-64DC-4ED3-A17D-7A32B1EED394Q48187879-3FC88A93-CA54-48C4-BE3C-5B64CACC5FF4Q48393851-DF2D55A8-6FDD-4325-8A5C-EC9349D34D4FQ51185958-74712EEA-491E-4446-8372-8A9BE4DCB06EQ58765919-1A7CFB77-0842-4CBB-A184-13E7C2F0E4C7
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Transportin1: a marker of FTLD-FUS
@ast
Transportin1: a marker of FTLD-FUS
@en
Transportin1: a marker of FTLD-FUS
@nl
type
label
Transportin1: a marker of FTLD-FUS
@ast
Transportin1: a marker of FTLD-FUS
@en
Transportin1: a marker of FTLD-FUS
@nl
prefLabel
Transportin1: a marker of FTLD-FUS
@ast
Transportin1: a marker of FTLD-FUS
@en
Transportin1: a marker of FTLD-FUS
@nl
P2093
P2860
P3181
P1476
Transportin1: a marker of FTLD-FUS
@en
P2093
Jack Brelstaff
Janice L Holton
Rina Bandopadhyay
Tamas Revesz
Tammaryn Lashley
P2860
P2888
P304
P3181
P356
10.1007/S00401-011-0863-6
P407
P577
2011-11-01T00:00:00Z
P5875
P6179
1006337986